JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB207204

FOXO1 Transcription Factor Assay Kit (Colorimetric)

Be the first to review this product! Submit a review

|

(8 Publications)

FOXO1 Transcription Factor Assay Kit (Colorimetric) (ab207204) is a high throughput assay to quantify FOXO1 activation in nuclear extracts.

View Alternative Names

FKHR, FOXO1A, FOXO1, Forkhead box protein O1, Forkhead box protein O1A, Forkhead in rhabdomyosarcoma

1 Images
Functional Studies - FOXO1 Transcription Factor Assay Kit (Colorimetric) (AB207204)
  • FuncS

Supplier Data

Functional Studies - FOXO1 Transcription Factor Assay Kit (Colorimetric) (AB207204)

Different amounts of nuclear extracts from untreated Raji (Black) and HeLa (Gray) cells are tested for FKHR activity. These results are provided for demonstration purposes only.

Different amounts of nuclear extracts from untreated HeLa (grey) and Raji (black) cells were tested for FOXO1 activity. These results are provided for demonstration purposes only.

Key facts

Detection method

Colorimetric

Sample types

Nuclear Extracts

Reacts with

Mouse, Rat, Human

Assay type

Semi-quantitative

Sensitivity

< 5000 ng/well

Assay time

3h 30m

Assay Platform

Microplate reader

Product details

FOXO1 Transcription Factor Assay Kit (Colorimetric) (ab207204) is a high throughput assay to quantify FOXO1 activation in nuclear extracts. This assay combines a quick ELISA format with a sensitive and specific non-radioactive assay for transcription factor activation.

A specific double stranded DNA sequence containing the FOXO1 consensus binding site (5' –TTGTTTAC– 3') has been immobilized onto a 96-well plate. Active FOXO1 present in the nuclear extract specifically binds to the oligonucleotide. FOXO1 is detected by a primary antibody that recognizes an epitope of FOXO1 accessible only when the protein is activated and bound to its target DNA. An HRP-conjugated secondary antibody provides sensitive colorimetric readout that at OD 450 nm. This product detects human, mouse and rat FOXO1.

Key performance and benefits:

  • Assay time: 3.5 hours (cell extracts preparation not included).
  • Detection limit: < 5 μg nuclear extract/well.
  • Detection range: 5 – 20 μg nuclear extract/well.

The Forkhead family of transcription factors are involved in regulation of the cell cycle, cell death, cell metabolism and oxidative stress. The FOXO (Forkhead Box, class O) proteins form a subfamily of Forkhead transcription factors that are direct targets of phosphoinositide 3-kinase (PI3K) mediated signal transduction. In the presence of growth factor/survival signals, PI3K activation leads to PDK mediated downstream activation of PKB/c-AKT. Phosphorylation and activation of PKB causes nuclear translocation of PKB, which phosphorylates and inactivates nuclear FOXO. FOXO then binds 14-3-3 proteins, and the FOXO/14-3-3 complex is exported to the cytoplasm. Phosphorylated, inactive FOXO proteins remain bound to 14-3-3 proteins in the cytoplasm, thereby preventing nuclear import of FOXO. In the absence of survival signals, cytoplasmic FOXO is dephosphorylated, causing dissociation from 14-3-3 proteins and allowing nuclear import of FOXO to activate gene expression.

There are three AKT phosphorylation sites in the FKHR protein: Thr24, Ser256 and Ser319. Specifically, phosphorylation at Ser256 is thought to play a role in masking a FKHR nuclear localization signal. In addition, phosphorylation at Ser256 may also mediate the effects of insulin on gene expression. Phosphorylation at Thr24 is critical for FKHR interaction with 14-3-3 proteins.

The most well studied FOXO members include acute-lymphocytic-leukaemia-1 fused gene from chromosome X (AFX/FOXO4), Forkhead in rhabdomyosarcoma (FKHR/FOXO1) and FKHR-Like 1 (FKHRL1/FOXO3a). AFX mRNA is expressed at high levels in heart and skeletal muscle, and moderately in brown and white adipose tissue. FKHR mRNA is detected at its highest levels in brown adipose tissue, white adipose tissue and spleen, with lower levels in liver and skeletal muscle. FKHRL1 mRNA is expressed at its highest levels in brain, heart, kidney and spleen, with moderate expression in white adipose tissue and testis.

In different cell types, FOXO proteins modulate various cellular activities. In hepatocytes, FOXO proteins regulate the expression of factors involved in gluconeogenesis, such as peroxisome proliferators-activated receptor-g coactivator-1, glucose-6-phosphate and phosphoenolpyruvate carboxykinase. Using genetic gain and loss of function analysis in mice, FKHR has also been shown to control b cell compensation for insulin resistance and glucose production in type 2 diabetes. In addition, FOXO proteins such as FKHRL1 have been shown to regulate catalase and superoxide dismutase gene expression that protect cells from oxidative stress, suggesting that FOXO factors act to control the mammalian lifespan.

While Forkhead transcription factors do not bind to a clear consensus sequence, the subclasses have been shown to bind to specific sequence elements. For example, FOXO and HNF subclasses of Forkhead proteins have been shown to bind to the insulin response elements (IREs) of insulin-like growth factor-binding protein-1 (IGFBP-1). FOXO transcription factors bind to a consensus core sequence of 5´-TTGTTTAC-3´, which includes a sequence TRTTTAY (with R a purine base and Y a pyrimidine base) conserved among various Forkhead members.

What's included?

{ "values": { "5x96Tests": { "sellingSize": "5 x 96 Tests", "publicAssetCode":"ab207204-5x96Tests", "assetComponentDetails": [ { "size":"1 x 500 µL", "name":"Mutated oligonucleotide (10 pmol/µL)", "number":"AB207204-CMP11" }, { "size":"1 x 500 µL", "name":"Wild-type oligonucleotide (10 pmol/µL)", "number":"AB207204-CMP16" }, { "size":"5 x 1 Unit", "name":"96-well FKHR assay plate", "number":"AB207204-CMP03" }, { "size":"5 x 1 Unit", "name":"Plate sealer", "number":"AB207204-CMP12" }, { "size":"1 x 110 mL", "name":"10X Wash Buffer", "number":"AB207204-CMP02" }, { "size":"1 x 50 mL", "name":"Binding Buffer", "number":"AB207204-CMP07" }, { "size":"1 x 500 µL", "name":"Protease Inhibitor Cocktail", "number":"AB207204-CMP13" }, { "size":"1 x 22 mL", "name":"10X Antibody Binding Buffer", "number":"AB207204-CMP01" }, { "size":"1 x 200 µL", "name":"Raji nuclear extract (2.5 µg/µL)", "number":"AB207204-CMP14" }, { "size":"1 x 55 µL", "name":"Anti-rabbit HRP-conjugated IgG", "number":"AB207204-CMP06" }, { "size":"1 x 55 mL", "name":"Stop Solution", "number":"AB207204-CMP15" }, { "size":"1 x 50 mL", "name":"Lysis Buffer", "number":"AB207204-CMP05" }, { "size":"1 x 60 µL", "name":"FKHR (FOXO1) antibody", "number":"AB207204-CMP10" }, { "size":"1 x 500 µL", "name":"Dithiothreitol (DTT) (1 M)", "number":"AB207204-CMP09" }, { "size":"1 x 500 µL", "name":"Herring sperm DNA", "number":"AB207204-CMP04" }, { "size":"1 x 55 mL", "name":"Developing Solution", "number":"AB207204-CMP08" } ] }, "1x96Tests": { "sellingSize": "1 x 96 Tests", "publicAssetCode":"ab207204-1x96Tests", "assetComponentDetails": [ { "size":"1 x 22 mL", "name":"10X Wash Buffer", "number":"AB207204-CMP02", "productcode":"" }, { "size":"1 x 100 µL", "name":"Mutated oligonucleotide (10 pmol/µL)", "number":"AB207204-CMP11", "productcode":"" }, { "size":"1 x 1 Unit", "name":"Plate sealer", "number":"AB207204-CMP12", "productcode":"" }, { "size":"1 x 100 µL", "name":"Wild-type oligonucleotide (10 pmol/µL)", "number":"AB207204-CMP16", "productcode":"" }, { "size":"1 x 1 Unit", "name":"96-well FKHR assay plate", "number":"AB207204-CMP03", "productcode":"" }, { "size":"1 x 40 µL", "name":"Raji nuclear extract (2.5 µg/µL)", "number":"AB207204-CMP14", "productcode":"" }, { "size":"1 x 100 µL", "name":"Herring sperm DNA", "number":"AB207204-CMP04", "productcode":"" }, { "size":"1 x 12 µL", "name":"FKHR (FOXO1) antibody", "number":"AB207204-CMP10", "productcode":"" }, { "size":"1 x 100 µL", "name":"Protease Inhibitor Cocktail", "number":"AB207204-CMP13", "productcode":"" }, { "size":"1 x 10 mL", "name":"Binding Buffer", "number":"AB207204-CMP07", "productcode":"" }, { "size":"1 x 2.2 mL", "name":"10X Antibody Binding Buffer", "number":"AB207204-CMP01", "productcode":"" }, { "size":"1 x 11 mL", "name":"Stop Solution", "number":"AB207204-CMP15", "productcode":"" }, { "size":"1 x 10 mL", "name":"Lysis Buffer", "number":"AB207204-CMP05", "productcode":"" }, { "size":"1 x 11 µL", "name":"Anti-rabbit HRP-conjugated IgG", "number":"AB207204-CMP06", "productcode":"" }, { "size":"1 x 11 mL", "name":"Developing Solution", "number":"AB207204-CMP08", "productcode":"" }, { "size":"1 x 100 µL", "name":"Dithiothreitol (DTT) (1 M)", "number":"AB207204-CMP09", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
Multi
Appropriate long-term storage conditions
Multi
Storage information
Please refer to protocols

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

FOXO1A also known as forkhead box O1 FOXO1 or FOXO1 transcription factor is a protein with a molecular weight of approximately 70 kDa. It is an important transcription factor in the FOXO family responsible for regulating gene expression in response to environmental and physiological stimuli. FOXO1A predominantly localizes in the nucleus but can translocate to the cytoplasm under certain conditions. Expression of FOXO1A occurs in various tissues including liver adipose tissue and pancreatic islets indicating its broad functional roles in different organs.
Biological function summary

FOXO1A acts as a regulator of metabolic pathways apoptosis and cell cycle regulation. Its role in glucose metabolism stands out as a critical function where it influences insulin signaling and glucose homeostasis. FOXO1A can also form complexes with other transcription factors like PPARγ enhancing its regulatory capacity. Interactions within these complexes dictate the transcriptional outcomes influencing cellular responses to stress and growth signals.

Pathways

The FOXO1 transcription factor plays a critical role in the insulin signaling and PI3K-Akt pathway. These pathways are essential for maintaining energy balance and cellular survival. FOXO1A interacts with proteins like Akt which phosphorylates FOXO1A resulting in its cytoplasmic sequestration and subsequent inactivation. This regulation is vital for insulin-mediated glucose uptake and overall metabolic homeostasis preserving cellular functions under fluctuating nutrient conditions.

Aberrant FOXO1A activity is associated with type 2 diabetes and certain cancers. Dysregulation leads to impaired insulin signaling and glucose metabolism contributing to insulin resistance and hyperglycemia in diabetes. In cancer altered FOXO1A expression affects apoptosis and cell proliferation influencing tumor progression and survival. Associations with proteins such as Akt and PPARγ in these conditions further exemplify its network in disease mechanisms highlighting its potential as a therapeutic target.

Product protocols

Target data

Transcription factor that is the main target of insulin signaling and regulates metabolic homeostasis in response to oxidative stress (PubMed : 10358076, PubMed : 12228231, PubMed : 15220471, PubMed : 15890677, PubMed : 18356527, PubMed : 19221179, PubMed : 20543840, PubMed : 21245099). Binds to the insulin response element (IRE) with consensus sequence 5'-TT[G/A]TTTTG-3' and the related Daf-16 family binding element (DBE) with consensus sequence 5'-TT[G/A]TTTAC-3' (PubMed : 10358076). Activity suppressed by insulin (PubMed : 10358076). Main regulator of redox balance and osteoblast numbers and controls bone mass (By similarity). Orchestrates the endocrine function of the skeleton in regulating glucose metabolism (By similarity). Also acts as a key regulator of chondrogenic commitment of skeletal progenitor cells in response to lipid availability : when lipids levels are low, translocates to the nucleus and promotes expression of SOX9, which induces chondrogenic commitment and suppresses fatty acid oxidation (By similarity). Acts synergistically with ATF4 to suppress osteocalcin/BGLAP activity, increasing glucose levels and triggering glucose intolerance and insulin insensitivity (By similarity). Also suppresses the transcriptional activity of RUNX2, an upstream activator of osteocalcin/BGLAP (By similarity). Acts as an inhibitor of glucose sensing in pancreatic beta cells by acting as a transcription repressor and suppressing expression of PDX1 (By similarity). In hepatocytes, promotes gluconeogenesis by acting together with PPARGC1A and CEBPA to activate the expression of genes such as IGFBP1, G6PC1 and PCK1 (By similarity). Also promotes gluconeogenesis by directly promoting expression of PPARGC1A and G6PC1 (PubMed : 17024043). Important regulator of cell death acting downstream of CDK1, PKB/AKT1 and STK4/MST1 (PubMed : 18356527, PubMed : 19221179). Promotes neural cell death (PubMed : 18356527). Mediates insulin action on adipose tissue (By similarity). Regulates the expression of adipogenic genes such as PPARG during preadipocyte differentiation and, adipocyte size and adipose tissue-specific gene expression in response to excessive calorie intake (By similarity). Regulates the transcriptional activity of GADD45A and repair of nitric oxide-damaged DNA in beta-cells (By similarity). Required for the autophagic cell death induction in response to starvation or oxidative stress in a transcription-independent manner (PubMed : 20543840). Mediates the function of MLIP in cardiomyocytes hypertrophy and cardiac remodeling (By similarity). Positive regulator of apoptosis in cardiac smooth muscle cells as a result of its transcriptional activation of pro-apoptotic genes (PubMed : 19483080). Regulates endothelial cell (EC) viability and apoptosis in a PPIA/CYPA-dependent manner via transcription of CCL2 and BCL2L11 which are involved in EC chemotaxis and apoptosis (PubMed : 31063815).
See full target information FOXO1

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

Nutrients 14: PubMed36145233

2022

Leucine Supplementation in Middle-Aged Male Mice Improved Aging-Induced Vascular Remodeling and Dysfunction via Activating the Sirt1-Foxo1 Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Zhujing Hao,Guiwen Xu,Mengyang Yuan,Ruopeng Tan,Yunlong Xia,Yang Liu,Xiaomeng Yin

Clinical cancer research : an official journal of the American Association for Cancer Research 28:3526-3536 PubMed35679032

2022

Deuterium Metabolic Imaging Reports on TERT Expression and Early Response to Therapy in Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Georgios Batsios,Céline Taglang,Meryssa Tran,Nicholas Stevers,Carter Barger,Anne Marie Gillespie,Sabrina M Ronen,Joseph F Costello,Pavithra Viswanath

Antioxidants (Basel, Switzerland) 11: PubMed35326118

2022

Antioxidant and Antiaging Properties of a Novel Synergistic Nutraceutical Complex: Readouts from an In Cellulo Study and an In Vivo Prospective, Randomized Trial.

Applications

Unspecified application

Species

Unspecified reactive species

Sophia Athanasopoulou,Marianna Kapetanou,Michel Georges Magouritsas,Nikoletta Mougkolia,Polykseni Taouxidou,Michael Papacharalambous,Fotios Sakellaridis,Efstathios Gonos

Frontiers in cell and developmental biology 9:625715 PubMed33634126

2021

FoxO1 Is a Novel Regulator of 20S Proteasome Subunits Expression and Activity.

Applications

Unspecified application

Species

Unspecified reactive species

Marianna Kapetanou,Tobias Nespital,Luke S Tain,Andre Pahl,Linda Partridge,Efstathios S Gonos

The FEBS journal 288:3317-3329 PubMed33245852

2020

Perturbed differentiation of murine embryonic stem cells upon Pelota deletion due to dysregulated FOXO1/β-catenin signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Manar Elkenani,Gunsmaa Nyamsuren,Karl Toischer,Ibrahim M Adham,Belal A Mohamed

Molecular medicine reports 20:2851-2858 PubMed31322188

2019

circRNA_0006393 promotes osteogenesis in glucocorticoid‑induced osteoporosis by sponging miR‑145‑5p and upregulating FOXO1.

Applications

Unspecified application

Species

Unspecified reactive species

Xing-Bo Wang,Peng-Biao Li,Shi-Fang Guo,Qing-Shan Yang,Zhi-Xin Chen,Dachuan Wang,Song-Bo Shi

Cellular signalling 61:66-77 PubMed31085234

2019

Hydrogen sulphide mitigates homocysteine-induced apoptosis and matrix remodelling in mesangial cells through Akt/FOXO1 signalling cascade.

Applications

Unspecified application

Species

Unspecified reactive species

Suravi Majumder,Lu Ren,Sathnur Pushpakumar,Utpal Sen

Molecular medicine reports 17:6621-6631 PubMed29512721

2018

HIF-1-mediated expression of Foxo1 serves an important role in the proliferation and apoptosis of osteoblasts derived from children's iliac cancellous bone.

Applications

Unspecified application

Species

Unspecified reactive species

Gang Xu
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com